Assembly Biosciences ASMB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31.12M+32.9% | $58.45M+52.4% | $22.53M-20.8% | $24.01M+25.0% | $23.41M+24.9% | ||
| $195.48M+189% | $189.66M+157% | $210.02M+216% | $50.97M-43.4% | $67.62M-28.2% | ||
| $451K— | $974K— | $912K— | $0— | -$0-100% | ||
| $5.56M+23.6% | $5.47M+59.7% | $3.34M+2.6% | $2.49M-33.0% | $4.5M+8.4% | ||
| $232.61M+144% | $254.55M+120% | $236.81M+141% | $77.47M-31.4% | $95.53M-18.5% | ||
| $214K-14.7% | $221K-22.2% | $229K-27.5% | $219K-37.2% | $251K-31.6% | ||
| $2.37M-19.1% | $2.51M-18.3% | $2.64M+86.1% | $2.78M+60.7% | $2.93M+43.8% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $235.51M+138% | $257.59M+116% | $240M+139% | $80.78M-30.0% | $99.02M-17.4% | ||
| $1.13M+29.0% | $1.17M+100% | $1.68M+26.1% | $743K-7.2% | $875K+20.4% | ||
| $2.66M+15.7% | $7.75M+12.9% | $5.73M+20.2% | $3.41M-5.0% | $2.3M+12.2% | ||
| $29.08M-28.8% | $36.9M-1.9% | $42.36M+29.9% | $40.92M+23.8% | $40.82M+24.6% | ||
| $590K+11.5% | $569K+23.4% | $548K-58.8% | $533K-58.8% | $529K-53.8% | ||
| $35M-24.9% | $48.78M+2.0% | $53.38M+28.2% | $47.29M+14.6% | $46.63M+20.3% | ||
| $1.9M-23.7% | $2.06M-21.7% | $2.21M+1,853% | $2.35M+421% | $2.49M+215% | ||
| $36.9M-48.7% | $50.84M-40.8% | $57.3M-22.8% | $62.68M-22.3% | $71.88M-17.6% | ||
| —— | —— | —— | —— | —— | ||
| $16K+100% | $16K+129% | $16K+167% | $8K+33.3% | $8K+60.0% | ||
| $1.04B+20.6% | $1.04B+20.9% | $1.04B+23.2% | $863.31M+2.7% | $862.12M+4.2% | ||
| -$841.13M-0.8% | -$832.05M-0.7% | -$854.14M-4.7% | -$844.94M-4.8% | -$834.74M-5.0% | ||
| -$368K-45.5% | -$41K+80.6% | -$90K+42.3% | -$279K+4.8% | -$253K-5.9% | ||
| $198.61M+632% | $206.75M+520% | $182.7M+603% | $18.1M-47.8% | $27.13M-16.8% | ||
| $235.51M+138% | $257.59M+116% | $240M+139% | $80.78M-30.0% | $99.02M-17.4% | ||
| $195.48M+189% | $189.66M+157% | $210.02M+216% | $50.97M-43.4% | $67.62M-28.2% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $2.37M-19.1% | $2.51M-18.3% | $2.64M+86.1% | $2.78M+60.7% | $2.93M+43.8% | ||
| $2.37M-19.1% | $2.51M-18.3% | $2.64M+86.1% | $2.78M+60.7% | $2.93M+43.8% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $2.37M-19.1% | $2.51M-18.3% | $2.64M+86.1% | $2.78M+60.7% | $2.93M+43.8% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $1.54M-27.0% | $2.39M+5.0% | $3.06M+92.8% | $1.69M-33.2% | $2.11M+2.3% | ||
| $2.49M-17.5% | $2.63M-14.9% | $2.76M+91.1% | $2.88M+65.2% | $3.02M+56.0% | ||
| $1.04B+20.6% | $1.04B+20.9% | $1.04B+23.2% | $863.31M+2.7% | $862.12M+4.2% | ||
| $16K+100% | $16K+129% | $16K+167% | $8K+33.3% | $8K+60.0% | ||
| $2.66M+15.7% | $7.75M+12.9% | $5.73M+20.2% | $3.41M-5.0% | $2.3M+12.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Assembly Biosciences's total assets?
- Assembly Biosciences (ASMB) holds $235.5M in total assets, up 137.8% year over year.
- How much debt does Assembly Biosciences have?
- Assembly Biosciences carries $2.5M in total debt against $198.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Assembly Biosciences have?
- Assembly Biosciences holds $31.1M in cash and equivalents.
- Can Assembly Biosciences cover its short-term obligations?
- Its current ratio is 6.65 — current assets exceed current liabilities.
- Where does Assembly Biosciences's balance sheet data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
